By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kadmon Corporation (Formerly Known As Kadmon Pharmaceuticals) 

Alexandria Center for Life Sciences
450 East 29th Street, 5th Floor
New York  New York  10016  U.S.A.
Phone: 212-308-6000 Fax: n/a




Company News
Kadmon Corporation Presents Data Demonstrating Role Of V-ATPase In EGFR Signaling 6/23/2015 1:33:46 PM
Kadmon Corporation Presents Data Demonstrating Potential Of ROCK2 Inhibition To Treat Lupus 6/22/2015 12:28:42 PM
Kadmon Corporation To Present At The JMP Securities Life Sciences Conference 2015 6/17/2015 2:27:50 PM
Kadmon Corporation To Present At 17th Sino-American Pharmaceutical Professionals Association New England (SAPA-NE) Annual Conference 6/12/2015 12:27:43 PM
Kadmon Corporation Announces Initial Phase 1b Data For Tesevatinib In Patients With Metastatic Breast Cancer 5/28/2015 10:47:19 AM
Kadmon Corporation To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/26/2015 11:56:34 AM
Kadmon Corporation's Immunology Research Recognized For Innovation By World Biomedical Frontiers 5/12/2015 11:28:27 AM
Kadmon Corporation Presents Data On Role Of ROCK2 Inhibition At AAI Annual Meeting 5/7/2015 1:31:50 PM
Kadmon Corporation Initiates Second Phase 2 Clinical Trial Evaluating KD026 In Type 2 Diabetes 5/4/2015 9:10:57 AM
Kadmon Corporation Launches New Gene Therapy Subsidiary 5/1/2015 7:46:16 AM